These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10768866)
1. Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients. Yamaguchi T; Kimura H; Yokota S; Yamamoto Y; Hashimoto T; Nakagawa M; Ito M; Ogura T Jpn J Clin Oncol; 2000 Feb; 30(2):53-8. PubMed ID: 10768866 [TBL] [Abstract][Full Text] [Related]
2. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Yamaguchi T; Yamamoto Y; Yokota S; Nakagawa M; Ito M; Ogura T Jpn J Clin Oncol; 1998 Dec; 28(12):740-4. PubMed ID: 9879291 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Nakano T; Chahinian AP; Shinjo M; Tonomura A; Miyake M; Togawa N; Ninomiya K; Higashino K Br J Cancer; 1998 Mar; 77(6):907-12. PubMed ID: 9528833 [TBL] [Abstract][Full Text] [Related]
4. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2. Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227 [TBL] [Abstract][Full Text] [Related]
10. WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions. Yang TM; Leu SW; Li JM; Hung MS; Lin CH; Lin YC; Huang TJ; Tsai YH; Yang CT J Cancer Res Clin Oncol; 2009 Jul; 135(7):919-24. PubMed ID: 19085002 [TBL] [Abstract][Full Text] [Related]
12. Unusual cytologic manifestation of small-cell lung cancer in associated pleural effusion. Smith R; Nguyen GK Diagn Cytopathol; 2004 Apr; 30(4):266-7. PubMed ID: 15048963 [No Abstract] [Full Text] [Related]
13. IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions. Takeuchi E; Yanagawa H; Suzuki Y; Shinkawa K; Ohmoto Y; Bando H; Sone S Lung Cancer; 2002 Feb; 35(2):171-7. PubMed ID: 11804690 [TBL] [Abstract][Full Text] [Related]
14. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells. Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675 [TBL] [Abstract][Full Text] [Related]
16. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion. Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828 [TBL] [Abstract][Full Text] [Related]
17. Presence and potent immunosuppressive role of interleukin-10 in malignant pleural effusion due to lung cancer. Yanagawa H; Takeuchi E; Suzuki Y; Ohmoto Y; Bando H; Sone S Cancer Lett; 1999 Feb; 136(1):27-32. PubMed ID: 10211935 [TBL] [Abstract][Full Text] [Related]
18. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Zhou WB; Bai M; Jin Y Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]